Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: GSK 10.595, Pfizer 14.451.
GSK vs Pfizer Net Worth and Market Cap
GSK (GSK) and Pfizer (PFE) are peers in Vaccines. GSK reported revenue of $10.6B as of Q2 2026, compared with $14.5B for Pfizer. Pfizer leads on revenue.
GSK's gross margin is 73.0% versus 67.3% for Pfizer. GSK's net margin is 5.2% versus 18.6% for Pfizer.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, GSK, Pfizer.| Metric | GSK | Pfizer |
|---|---|---|
| Market Cap | - | - |
| Revenue | $10.60B | $14.45B |
| Cost of Revenue | $2.85B | $4.73B |
| Gross Profit | $7.74B | $9.72B |
| Operating Income | $606.00M | $4.03B |
| Net Income | $548.00M | $2.69B |
| R&D Expense | $4.37B | $2.63B |
| Earnings Per Share | $0.28 | $0.47 |
| Gross Margin | 73.0% | 67.3% |
| Operating Margin | 5.7% | 27.9% |
| Net Profit Margin | 5.2% | 18.6% |
| Free Cash Flow | $2.78B | $2.18B |
| Cumulative Free Cash Flow | $157.21B | $356.40B |
| Operating Cash Flow | $3.19B | $2.62B |
| Cash & Equivalents | $3.89B | $1.70B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.